These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26468984)

  • 101. MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way.
    Fang S; Zheng L; Chen X; Guo X; Ding Y; Ma J; Ding J; Chen W; Yang Y; Chen M; Zhao Z; Tu J; Ji J
    Hepatol Int; 2023 Dec; 17(6):1500-1518. PubMed ID: 37460832
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.
    Weygant N; Qu D; Berry WL; May R; Chandrakesan P; Owen DB; Sureban SM; Ali N; Janknecht R; Houchen CW
    Mol Cancer; 2014 May; 13():103. PubMed ID: 24885928
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis.
    Ito H; Tanaka S; Akiyama Y; Shimada S; Adikrisna R; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Yamaoka S; Tanabe M
    PLoS One; 2016; 11(1):e0146564. PubMed ID: 26764906
    [TBL] [Abstract][Full Text] [Related]  

  • 104. DCLK1 Expression and its Functional Significance in Intrahepatic Cholangiocarcinoma and Bil-IN Stage.
    Fukushima NM; Adachi T; Tanaka T; Matsushima H; Imamura H; Hara T; Soyama A; Hidaka M; Kanetaka K; Eguchi S
    Anticancer Res; 2024 Jun; 44(6):2417-2424. PubMed ID: 38821583
    [TBL] [Abstract][Full Text] [Related]  

  • 105. MicroRNAs as Plasma Biomarkers of Hepatocellular Carcinoma in Patients with Liver Cirrhosis-A Cross-Sectional Study.
    Zenlander R; Salter H; Gilg S; Eggertsen G; Stål P
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397091
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer.
    Dogra S; Elayapillai SP; Qu D; Pitts K; Filatenkov A; Houchen CW; Berry WL; Moxley K; Hannafon BN
    Cancer Lett; 2023 Dec; 578():216437. PubMed ID: 37838282
    [TBL] [Abstract][Full Text] [Related]  

  • 107. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo.
    Yin L; Keeler GD; Zhang Y; Hoffman BE; Ling C; Qing K; Srivastava A
    Gene Ther; 2021 Aug; 28(7-8):422-434. PubMed ID: 32152434
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Preferential targeting of disseminated liver tumors using a recombinant adeno-associated viral vector.
    Della Peruta M; Badar A; Rosales C; Chokshi S; Kia A; Nathwani D; Galante E; Yan R; Arstad E; Davidoff AM; Williams R; Lythgoe MF; Nathwani AC
    Hum Gene Ther; 2015 Feb; 26(2):94-103. PubMed ID: 25569358
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma.
    Standing D; Arnold L; Dandawate P; Ottemann B; Snyder V; Ponnurangam S; Sayed A; Subramaniam D; Srinivasan P; Choudhury S; New J; Kwatra D; Ramamoorthy P; Roy BC; Shadoin M; Al-Rajabi R; O'Neil M; Gunewardena S; Ashcraft J; Umar S; Weir SJ; Tawfik O; Padhye SB; Biersack B; Anant S; Thomas SM
    Mol Carcinog; 2023 Feb; 62(2):145-159. PubMed ID: 36218231
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells.
    Moore LL; Houchen CW
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003596
    [TBL] [Abstract][Full Text] [Related]  

  • 111. miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism.
    Hu Y; Setayesh T; Vaziri F; Wu X; Hwang ST; Chen X; Yvonne Wan YJ
    Mol Ther; 2023 Jun; 31(6):1829-1845. PubMed ID: 37143325
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing.
    Liu Y; Ferguson FM; Li L; Kuljanin M; Mills CE; Subramanian K; Harshbarger W; Gondi S; Wang J; Sorger PK; Mancias JD; Gray NS; Westover KD
    Cell Chem Biol; 2020 Oct; 27(10):1229-1240.e4. PubMed ID: 32755567
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Folate deficient tumor microenvironment promotes epithelial-to-mesenchymal transition and cancer stem-like phenotypes.
    Su YH; Huang WC; Huang TH; Huang YJ; Sue YK; Huynh TT; Hsiao M; Liu TZ; Wu AT; Lin CM
    Oncotarget; 2016 May; 7(22):33246-56. PubMed ID: 27119349
    [TBL] [Abstract][Full Text] [Related]  

  • 114. ZNF131 facilitates the growth of hepatocellular carcinoma by acting as a transcriptional activator of SMC4 expression.
    Jin M; Mi Y; Li F; Ren F; Deng Y; Zheng P
    Biochem Biophys Res Commun; 2024 Feb; 696():149515. PubMed ID: 38241815
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Synthetic switch-based baculovirus for transgene expression control and selective killing of hepatocellular carcinoma cells.
    Lin MW; Tseng YW; Shen CC; Hsu MN; Hwu JR; Chang CW; Yeh CJ; Chou MY; Wu JC; Hu YC
    Nucleic Acids Res; 2018 Sep; 46(15):e93. PubMed ID: 29905834
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma.
    Sung YK; Hwang SY; Park MK; Bae HI; Kim WH; Kim JC; Kim M
    Cancer Sci; 2003 May; 94(5):421-4. PubMed ID: 12824887
    [TBL] [Abstract][Full Text] [Related]  

  • 117. DCLK1 is Overexpressed and Associated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Velázquez-Enríquez JM; Cerna R; Beltrán-Ramírez O; Piña-Vázquez C; Villa-Treviño S; Vásquez-Garzón VR
    Biochem Genet; 2024 Jan; ():. PubMed ID: 38294590
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Identify GADD45G as a potential target of 4-methoxydalbergione in treatment of liver cancer: bioinformatics analysis and in vivo experiment.
    Zeng LP; Qin YQ; Lu XM; Feng ZB; Fang XL
    World J Surg Oncol; 2023 Oct; 21(1):324. PubMed ID: 37833694
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma.
    Arbuthnot P; Thompson LJ
    World J Gastroenterol; 2008 Mar; 14(11):1670-81. PubMed ID: 18350598
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation.
    Pan P; Ji D; Li Z; Meng X
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2287990. PubMed ID: 38062554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.